Filter
397
Text search:
Y.
Yu
Featured
Recommendations
48
New Publications
42
Language
Document type
Guidelines
122
No document type
121
Studies & Reports
96
Manuals
21
Fact sheets
17
Strategic & Response Plan
12
Infographics
3
Training Material
2
Situation Updates
2
Resource Platforms
1
Countries / Regions
Russia
20
Brazil
17
Global
17
Latin America and the Carribbean
12
Germany
10
Argentina
10
Vietnam
9
South Africa
8
Middle East and North Africa
8
Paraguay
8
Philippines
6
Rwanda
6
Ukraine
6
Myanmar / Burma
6
Spain
6
India
5
Syria
5
Cambodia
5
Mozambique
5
Ecuador
5
Western and Central Europe
5
Laos
5
Peru
4
Yemen
4
East and Southern Africa
4
West and Central Africa
4
Eastern Europe
4
Nigeria
3
Ghana
3
Kenya
3
China
3
Angola
3
Chile
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Africa
3
Guinea-Bissau
2
Uganda
2
Colombia
2
Western Pacific Region
2
Asia
2
Sierra Leone
1
Senegal
1
Congo, Democratic Republic of
1
Mali
1
Ethiopia
1
Cameroon
1
Zimbabwe
1
South Sudan
1
Lebanon
1
Tanzania
1
Thailand
1
Indonesia
1
Malaysia
1
Malawi
1
Sudan
1
Austria
1
Switzerland
1
Guatemala
1
Lesotho
1
Venezuela
1
Japan
1
France
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
142
Public Health
28
Clinical Guidelines
19
Key Resources
8
Women & Child Health
6
Pharmacy & Technologies
6
Toolboxes
COVID-19
145
Mental Health
33
Planetary Health
23
HIV
22
TB
20
Disability
16
AMR
15
Rapid Response
12
NTDs
12
NCDs
11
Pharmacy
9
Caregiver
8
Ebola
5
Refugee
5
Zika
4
Polio
3
Global Health Education
2
Health Financing Toolbox
2
Cholera
1
Conflict
1
This document, Programme and curriculum development guide, presents a systematic approach to developing programmes and curricula for implementation of the family planning (FP) and comprehensive abortion care (CAC) competencies,and the theory behind the approach. Specifically, the aim is for effectiv
...
Le syndrome respiratoire aigu provoqué par le coronavirus-2 (SARS-CoV-2), initialement décrit en Chine, est responsable
de la pandémie que nous connaissons actuellement sous le nom de coronavirus disease 2019 ou COVID-19. L'épidémie de
coronavirus a été déclarée « urgence de santé publi
...
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known. It is currently unknown what the incidence, prevalence and the number of reported
...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines
...
Rabies remains an under-reported neglected zoonosis with a case-fatality rate of almost 100% in humans and animals. Dog-mediated human rabies causes tens of thousands of human deaths annually despite being 100% preventable. More than 95% of human cases are caused by the bite of a rabies-infected dog
...
The Sustainable Development Goals (SDGs) call for major societal transformations that will require significant fiscal outlays as well as private investments. The fiscal outlays cover public investments, the public provision of social services, and social protection for vulnerable populations. The ke
...
This paper introduces a new dataset of official financing—including foreign aid and other forms of concessional and non-concessional state financing—from China to 138 countries between 2000 and 2014. We use these data to investigate whether and to what extent Chinese aid affects economic growth
...
To better adapt current case management practices and address excess mortality in otherwise treatable
cases will require better knowledge of the demographic characteristics of the patients and comorbidities
which can make severe dehydration harder to tolerate physiologically. With this in mind, a
...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the
...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del
...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit
...
Objective: To identify gaps in national stroke guidelines that could be bridged to enhance the quality of stroke care services in low- and
middle-income countries.
Methods: We systematically searched medical databases and websites of medical societies and contacted international organizations.
Co
...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom
...
The document "Global Report on Diabetes" by the World Health Organization (WHO) provides an in-depth analysis of diabetes as a global health challenge. It covers the rising prevalence of the disease, the associated risk factors, and the increasing burden on healthcare systems, particularly in low- a
...
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom
...
Silicosis is not a new disease; the impact of silica dust on respiratory function was observed by Hippocrates in 430 B.C. and in the 16th century by Agricol. In 1713, Rammazini described silicotic nodules in post-mortems of stone cutters presenting with respiratory symptoms. In the mid-late 1800s,
...
interim guidance, 25 November 2024
